Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tocilizumab in critically ill patients with COVID-19
RBR-3zdynpPhase 4Recruiting
- Sponsor
- Victor Côrtes Pourchet de Carvalho
- Start
- Mar 2020
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of tocilizumab in coronavirus disease 2019 (COVID-19), sponsored by Victor Côrtes Pourchet de Carvalho. Started Mar 2020; status: recruiting.
02
Drugs
tocilizumab
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on RBR-3zdynp.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-3zdynp.